INS and type 2 diabetes mellitus: One, longer-term, cross over study with a 12-week treatment duration found postprandial insulin values were significantly increased while the favorable reductions in fasting plasma glucose (-7.3%), fasting plasma insulin (-5.9%) and post-prandial glucose values (-20%) were not statistically significant for the eleven T2DM male subjects in this trial [42].